内皮细胞源决定了在促炎环境中纤维解质标记物的表达和释放
Steven J Humphreys1, Nicola J Mutch1, Claire S Whyte1
1Aberdeen Cardiovascular and Diabetes Centre, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
Research and practice in thrombosis and haemostasis
|July 25, 2025
概括
人类冠状动脉内皮细胞 (HCAECs) 对炎症表现出比人类静脉内皮细胞 (HUVECs) 更强大的低纤维素溶解反应. 这突出了HCAEC作为研究抗血栓策略的模型.
科学领域:
- 血管生物学 血管生物学
- 血液静止和血栓形成
- 内皮细胞生物学 内皮细胞生物学
背景情况:
- 内皮细胞 (ECs) 对于静血至关重要,调节分子相互作用和分泌关键因素.
- 炎症性细胞因子可以破坏血管微环境,导致内皮功能障碍和血液静止改变.
研究的目的:
- 为了研究来自不同血管床的内皮细胞的纤维溶解平衡.
- 为了确定这些内皮细胞对促炎性刺激的反应.
主要方法:
- 主要人类静脉ECs (HUVECs) 和人类冠状动脉ECs (HCAECs) 在不同的剪切应力条件下培养.
- 通过使用血栓素,白内素-6或瘤缩因子-α (TNF-α) 刺激ECs.
- 使用qPCR,ELISA和活性试验量化凝血和纤维解蛋白表达和分泌;监测血凝块溶解.
主要成果:
- 与HUVEC相比,HCAEC表现出较高的C-反应蛋白,尿素激酶激活剂 (uPA) 和激活剂抑制剂-1 (PAI-1) 的基底分泌.
- TNF-α刺激显著增加了HCAEC中的tPA,uPA和PAI-1分泌,导致tPA/PAI-1和uPA/PAI-1比率更高,并增加了自由活性PAI-1.
- HCAECs和HUVECs延迟了凝块溶解,这种效应通过PAI-1中和得到正常化;TNF-α刺激以PAI-1依赖的方式延长了HCAECs中的凝块溶解.
结论:
- 人类冠状动脉ECs (HCAECs) 与HUVECs相比,对促炎性刺激的反应更为强烈.
- HCAECs表现出改变的纤维解蛋白表达,在炎症条件下促进低纤维解蛋白状态.
- HCAEC 作为冠状动脉血管系统的宝贵模型,适合选新型抗血栓策略.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Inflammation
55.2K
Overview
55.2K
Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K
Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K


